Comments on: Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis

Comments on: Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford Biomedica Announce New Partnership to Develop First-in-Class Gene Therapy for Cystic Fibrosis https://www.novumpr.nl/2018/08/06/boehringer-ingelheim-the-uk-cystic-fibrosis-gene-therapy-consortium-imperial-innovations-and-oxford-biomedica-announce-new-partnership-to-develop-first-in-class-gene-therapy-for-cystic-fibrosis/?utm_source=rss&utm_medium=rss&utm_campaign=boehringer-ingelheim-the-uk-cystic-fibrosis-gene-therapy-consortium-imperial-innovations-and-oxford-biomedica-announce-new-partnership-to-develop-first-in-class-gene-therapy-for-cystic-fibrosis NovumPR press releases Mon, 06 Aug 2018 08:06:18 +0000 hourly 1 https://wordpress.org/?v=6.8.3